Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Smaldone Alsup Laurie Create: Alert

All | News | Filings
Date FiledTypeDescription
06/01/2023 4 Smaldone Alsup Laurie (Director) has filed a Form 4 on BLACKBERRY Ltd
Txns: Granted 9,259 restricted stock units @ $0
05/04/2023 4 Smaldone Alsup Laurie (Director) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Granted 9,132 shares @ $0
Granted 22,044 options to buy @ $10.95, valued at $241.4k
03/01/2023 4 Smaldone Alsup Laurie (Director) has filed a Form 4 on BLACKBERRY Ltd
Txns: Granted 12,736 restricted stock units @ $0
12/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/16/2022 4 Smaldone Alsup Laurie (Director) has filed a Form 4 on PARDES BIOSCIENCES, INC.
Txns: Granted 75,000 options to buy @ $2.98, valued at $223.5k
09/01/2022 4 Smaldone Alsup Laurie (Director) has filed a Form 4 on BLACKBERRY Ltd
Txns: Granted 8,653 restricted stock units @ $0
06/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2022 4 Smaldone Alsup Laurie (Director) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Granted 20,250 options to buy @ $8.38, valued at $169.7k
06/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/28/2022 4 Smaldone Alsup Laurie (Director) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Granted 9,852 shares @ $0
Granted 28,000 options to buy @ $10.15, valued at $284.2k
03/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/14/2021 4 Smaldone Alsup Laurie (Director) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Granted 20,250 options to buy @ $24.46, valued at $495.3k
06/10/2021 4 Smaldone Alsup Laurie (Director) has filed a Form 4 on ARVINAS, INC.
Txns: Granted 7,511 options to buy @ $78.53, valued at $589.8k
06/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/29/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/02/2020 4 Smaldone Alsup Laurie (Director) has filed a Form 4 on BLACKBERRY Ltd
Txns: Granted 8,823 restricted stock units @ $0
09/02/2020 4 Smaldone Alsup Laurie (Director) has filed a Form 4 on BLACKBERRY Ltd
Txns: Granted 9,927 restricted stock units @ $0
06/04/2020 4 Smaldone Alsup Laurie (Director) has filed a Form 4 on ARVINAS, INC.
Txns: Granted 12,000 options to buy @ $33.57, valued at $402.8k
06/01/2020 4 Smaldone Alsup Laurie (Director) has filed a Form 4 on BLACKBERRY Ltd
Txns: Granted 10,547 restricted stock units @ $0
04/30/2020 4 Smaldone Alsup Laurie (Director) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Granted 6,635 shares @ $0
Granted 6,000 options to buy @ $30.14, valued at $180.8k
11/22/2019 4 Smaldone Alsup Laurie (Director) has filed a Form 4 on ARVINAS, INC.
Txns: Granted 25,846 options to buy @ $34.07, valued at $880.6k
05/02/2019 4 Smaldone Alsup Laurie (Director) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Granted 8,385 shares @ $0
Granted 6,000 options to buy @ $23.85, valued at $143.1k
05/03/2018 4 Smaldone Alsup Laurie (Director) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Granted 8,186 shares @ $0
Granted 6,000 options to buy @ $24.43, valued at $146.6k
02/15/2018 4 Smaldone Alsup Laurie (Director) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Granted 1,776 shares @ $0
Granted 12,000 options to buy @ $28.14, valued at $337.7k
Granted 1,500 options to buy @ $28.14, valued at $42.2k
07/14/2015 4 Smaldone Alsup Laurie (Director) has filed a Form 4 on KALOBIOS PHARMACEUTICALS INC
Txns: Granted 5,000 options to buy @ $0
06/20/2014 4 Form 4 - Statement of changes in beneficial ownership of securities
10/23/2013 4 Form 4 - Statement of changes in beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy